Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.
Market Cap
$2.98B
P/E Ratio
-37.69
1Y Stock Return
-11.66%
1Y Revenue Growth
22.41%
Dividend Yield
0.00%
Price to Book
6.9
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DAVA | 43.41% | $1.16B | -59.28% | 0.00% |
XMTR | 39.39% | $1.48B | +50.13% | 0.00% |
SDGR | 38.41% | $1.38B | -35.46% | 0.00% |
MMSI | 33.61% | $6.10B | +45.96% | 0.00% |
TRS | 33.00% | $1.06B | +9.03% | 0.61% |
DMRC | 32.82% | $694.39M | -2.06% | 0.00% |
IRWD | 32.32% | $609.71M | -59.34% | 0.00% |
INCY | 31.71% | $13.59B | +32.56% | 0.00% |
AMPH | 30.79% | $2.10B | -23.00% | 0.00% |
EVTC | 30.62% | $2.27B | -1.27% | 0.56% |
EDIT | 30.60% | $204.72M | -75.49% | 0.00% |
LIVN | 30.54% | $2.79B | +18.18% | 0.00% |
RELY | 29.99% | $3.96B | -7.42% | 0.00% |
OSW | 29.83% | $1.95B | +65.90% | 0.21% |
GPRO | 29.23% | $179.52M | -67.23% | 0.00% |
LMAT | 29.12% | $2.33B | +94.89% | 0.46% |
RGR | 29.04% | $642.75M | -15.87% | 1.81% |
CSTL | 28.94% | $808.57M | +48.97% | 0.00% |
KIDS | 28.84% | $588.93M | -24.59% | 0.00% |
SRDX | 28.58% | $559.12M | +15.64% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AA | -<0.01% | $11.78B | +72.79% | 0.88% |
ADNT | 0.01% | $1.65B | -41.00% | 0.00% |
BWXT | 0.01% | $11.92B | +67.39% | 0.91% |
EXC | 0.02% | $39.29B | +0.57% | 3.88% |
CSL | 0.02% | $19.72B | +59.12% | 0.85% |
GIB.A | 0.03% | $24.72B | +8.31% | 0.00% |
BILI | 0.03% | $6.14B | +30.79% | 0.00% |
ESRT | 0.04% | $1.82B | +25.43% | 1.29% |
NYT | 0.05% | $8.54B | +15.47% | 0.96% |
BXMT | -0.05% | $3.23B | -15.15% | 12.51% |
NAT | 0.06% | $636.83M | -30.05% | 13.79% |
VIAV | -0.06% | $2.16B | +23.26% | 0.00% |
GIS | -0.06% | $34.85B | -2.91% | 3.78% |
APAM | -0.06% | $3.25B | +26.70% | 6.08% |
BOC | -0.06% | $456.18M | -1.56% | 0.00% |
IPG | 0.07% | $10.30B | -8.50% | 4.72% |
SOHU | -0.08% | $406.50M | +43.52% | 0.00% |
CEIX | -0.08% | $3.72B | +24.89% | 0.39% |
KEY | 0.09% | $18.83B | +58.20% | 4.30% |
SITM | 0.09% | $4.87B | +81.01% | 0.00% |
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
Morgan Stanley's latest report pegs the BCI market at $400 billion — signaling to investors that this revolutionary technology is the next big bet in medtech.
Yahoo
Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund appreciated 13.55% (Institutional Shares), outperforming the 8.41% return for the Russell 2000 Growth Index. Year-to-date, the fund returned 9.50% compared to the index’s 13.22% […]
Yahoo
IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today its management team will present at the upcoming Jefferies London Healthcare Conference on Wednesday, November 20, 2024, at 10:00 AM Greenwich Mean Time / 5:00 AM Eastern Time. A live audio webcast and replay of the presentation may be accessed for 30 days on t
Yahoo
The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the companies and their device markets.
Yahoo
Inari Medical ( NASDAQ:NARI ) Third Quarter 2024 Results Key Financial Results Revenue: US$153.4m (up 21% from 3Q...
Yahoo
Inari Medical Inc (NARI) reports strong revenue growth and raises full-year guidance, despite facing increased expenses and operating losses.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CVI | -22.52% | $1.89B | -40.56% | 7.98% |
KODK | -22.13% | $422.90M | +41.40% | 0.00% |
TPST | -21.96% | $37.75M | -77.59% | 0.00% |
HRL | -19.58% | $16.30B | -8.38% | 3.81% |
HUSA | -18.22% | $16.69M | -11.56% | 0.00% |
CNQ | -16.74% | $71.04B | +1.89% | 6.81% |
JNPR | -16.23% | $11.61B | +30.55% | 2.49% |
PSTG | -16.00% | $16.35B | +36.41% | 0.00% |
AUDC | -15.44% | $262.07M | -18.71% | 4.14% |
VRN | -15.07% | $3.23B | -25.43% | 6.21% |
PTVE | -14.84% | $2.25B | +12.14% | 3.19% |
VLO | -14.64% | $44.96B | +15.30% | 2.28% |
IMO | -14.60% | $39.72B | +31.84% | 2.23% |
VIST | -14.42% | $4.75B | +67.10% | 0.00% |
AVGO | -14.33% | $772.28B | +68.52% | 9.87% |
VERX | -14.28% | $7.99B | +89.70% | 0.00% |
COR | -13.81% | $47.48B | +21.20% | 0.86% |
GCT | -13.79% | $983.16M | +147.95% | 0.00% |
SU | -13.58% | $52.05B | +23.58% | 3.92% |
RYN | -13.54% | $4.48B | -2.31% | 3.80% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USCI | -19.89% | $185.47M | 1.07% |
DBE | -19.27% | $50.13M | 0.77% |
GSG | -18.72% | $914.42M | 0.75% |
DBO | -18.57% | $217.57M | 0.77% |
COMT | -18.22% | $829.06M | 0.48% |
TPMN | -17.94% | $40.60M | 0.65% |
PDBC | -16.39% | $4.40B | 0.59% |
DBC | -15.53% | $1.39B | 0.87% |
HIGH | -15.32% | $302.78M | 0.51% |
BTAL | -13.81% | $388.04M | 1.43% |
GCC | -13.68% | $133.23M | 0.55% |
EFAA | -13.37% | $117.38M | 0% |
FTGC | -13.35% | $2.17B | 1.02% |
MSOS | -13.18% | $632.80M | 0.83% |
MUST | -13.18% | $410.00M | 0.23% |
FXN | -12.59% | $416.11M | 0.62% |
BCD | -12.59% | $245.02M | 0.3% |
IGE | -11.92% | $634.87M | 0.41% |
CMDY | -11.52% | $279.14M | 0.28% |
FCG | -11.02% | $395.85M | 0.6% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IEF | -0.04% | $32.30B | 0.15% |
EWC | 0.05% | $2.79B | 0.5% |
GOVT | 0.05% | $28.65B | 0.05% |
AGGY | -0.07% | $926.64M | 0.12% |
BNDW | 0.12% | $854.64M | 0.05% |
BOND | 0.13% | $5.01B | 0.58% |
LDSF | 0.13% | $131.03M | 0.75% |
CORN | 0.14% | $61.12M | 0.2% |
HEQT | 0.14% | $254.30M | 0.53% |
MTUM | -0.15% | $13.13B | 0.15% |
RPAR | 0.15% | $591.64M | 0.5% |
EPHE | 0.15% | $99.70M | 0.59% |
XHLF | 0.16% | $874.27M | 0.03% |
ILTB | -0.16% | $604.33M | 0.06% |
DFCF | 0.16% | $5.80B | 0.17% |
FIXD | -0.17% | $5.51B | 0.65% |
GTIP | 0.17% | $136.50M | 0.12% |
RPG | 0.17% | $1.52B | 0.35% |
RLY | 0.17% | $491.79M | 0.5% |
FEPI | -0.19% | $406.41M | 0.65% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XHE | 41.95% | $213.41M | 0.35% |
XBI | 33.07% | $6.58B | 0.35% |
PTH | 32.11% | $143.31M | 0.6% |
IHI | 31.28% | $4.91B | 0.4% |
RSPH | 30.92% | $885.96M | 0.4% |
FXH | 30.47% | $1.15B | 0.62% |
IBB | 30.43% | $6.66B | 0.45% |
PBE | 30.09% | $258.53M | 0.58% |
FHLC | 29.85% | $2.73B | 0.084% |
VHT | 29.72% | $17.06B | 0.1% |
FBT | 29.68% | $1.11B | 0.56% |
BBH | 29.62% | $397.87M | 0.35% |
PINK | 29.23% | $161.15M | 0.5% |
ARKG | 29.08% | $1.13B | 0.75% |
GNOM | 28.01% | $70.59M | 0.5% |
XPH | 27.98% | $157.87M | 0.35% |
IHE | 27.86% | $596.23M | 0.39% |
IYH | 27.34% | $3.19B | 0.39% |
EDOC | 27.17% | $40.86M | 0.68% |
XSW | 26.72% | $402.79M | 0.35% |
Current Value
$50.831 Year Return
Current Value
$50.831 Year Return